Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

NCT00002234 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Efavirenz
DRUG: Adefovir dipivoxil
DRUG: Lamivudine
DRUG: Didanosine

Sponsor

Gilead Sciences

Collaborators

[object Object]
[object Object]
[object Object]